Literature DB >> 8588421

Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors.

M F Herrera1, C M López-Graniel, J Saldaña, A Gamboa-Domínguez, Y Richaud-Patín, F Vargas-Vorackova, A Angeles-Angeles, L Llorente, C Castillo, B Pérez, R Rivera, O González, J Rull.   

Abstract

The present study characterizes papillary thyroid carcinoma (PTC) in a Mexican patient sample and evaluates potential prognostic factors for recurrence. Clinical records of 229 patients with PTC were analyzed. Surgical specimens were rereviewed and DNA ploidy determined. Cox logistic regression was used to explore prognostic factors. Mean age +/- SD of the patients was 42 +/- 16 years, with a male/female ratio of 24:205. A thyroid mass was the initial manifestation in 99%. Extrathyroid invasion occurred in 45% and nodal metastases in 38%. Mean size +/- SD of the tumors was 3 +/- 2 cm. By flow cytometry 88% of the tumors were DNA euploid and 12% aneuploid. Complete tumor resection was achieved in 83% with an operative mortality of 0.4%. Postoperative hormone suppression was administered in 65% and remnant 131I thyroid ablation in 84%. The 10-year recurrence-free survival was 85%. In the group of patients with tumors totally removed and without distant metastases, none of the 14 evaluated variables demonstrated statistical significance as an independent prognostic factor for recurrence. However, the group of patients in whom a combination of the following factors was present--age > or = 40 years, tumor size > or = 3 cm, local invasion, and lymph node metastases--showed a higher incidence of tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8588421     DOI: 10.1007/s002689900017

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  6 in total

1.  A less invasive, selective, functional neck dissection for papillary thyroid carcinoma.

Authors:  G Ardito; F Rulli; L Revelli; F Moschella; G Galatà; E Giustozzi; F Ardito; A M Farinon
Journal:  Langenbecks Arch Surg       Date:  2005-08-16       Impact factor: 3.445

2.  Recurrent Papillary Thyroid Carcinoma to the Cervical Lymph Nodes: Outcomes of Compartment-Oriented Lymph Node Resection.

Authors:  Carlos Gustavo Rivera-Robledo; David Velázquez-Fernández; Juan Pablo Pantoja; Mauricio Sierra; Bernardo Pérez-Enriquez; Raul Rivera-Moscoso; Mónica Chapa; Miguel F Herrera
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

3.  Macrofollicular Variant of Papillary Thyroid Carcinoma: A Case and Control Analysis.

Authors:  Armando Gamboa-Dominguez; Isabel Vieitez-Martinez; Blanca A. Barredo-Prieto; Yvonne Richaud-Patin; Miguel E. Herrera; Arturo Angeles-Angeles
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

4.  Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment.

Authors:  Chandrasekhar Bal; Sanjana Ballal; Ramya Soundararajan; Saurav Chopra; Aayushi Garg
Journal:  Cancer Med       Date:  2015-03-09       Impact factor: 4.452

5.  Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages.

Authors:  Xuhang Zhu; Bin Yu; Yu-Qing Huang; Jing-Nan Zhou; Ming-Hua Ge
Journal:  Int J Endocrinol       Date:  2017-03-03       Impact factor: 3.257

6.  Regional Node Distribution in Papillary Thyroid Cancer with Microscopic Metastasis.

Authors:  Luis-Mauricio Hurtado-López; Alejandro Ordoñez-Rueda; Felipe-Rafael Zaldivar-Ramírez; Erich Basurto-Kuba
Journal:  J Thyroid Res       Date:  2018-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.